Pharma and biotech sector leads the way in global M&A deals

The pharma, medical and biotech industry is the most active sector for mergers and acquisitions so far this year, with deals valued at $252.5 billion, according to Mergermarket.

The sector represented a 16.9% market share in global M&A, which stands at $1,494 billion, up 48.6% compared to the first half of 2013 ($1,005 billion), and up 23.5% compared to the second half of 2013. In pharma, medical and biotech, deal value is 48.2% above the whole of 2013’s value, is a result of four of the 10 highest valued global deals targeting this sector – these four deals account for a 61.3% share in the sector’s total activity.